SCHEMBL7320641

SCHEMBL7320641

NCC(=O)N(C(=O)CO)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NPC1 O15118 2/20 0.41
HTT P42858 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
ADRA2C P18825 1/20 0.38
AOC3 Q16853 1/20 0.37
GLA P06280 2/20 0.37
TSHR P16473 1/20 0.37
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
PAX8 Q06710 1/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15667384 0.92 ALDH1A1 (0.47) GAAALDH1A1KMT2ANPSR1NPC1
SCHEMBL27434141 0.82 ALDH1A1 (0.42) ALDH1A1KMT2ANPSR1NPC1HTT
SCHEMBL11648159 0.81 CRHBP (0.46) GAAALDH1A1KMT2ANPSR1NPC1
SCHEMBL11282246 0.79 ADRA2C (0.51) GAAALDH1A1KMT2ANPSR1NPC1
SCHEMBL27337089 0.76 ALDH1A1 (0.44) ALDH1A1KMT2ANPSR1NPC1HTT
SCHEMBL1561385 0.75 ALDH1A1 (0.63) GAAALDH1A1KMT2ANPSR1NPC1
SCHEMBL27675508 0.75 GAA (0.45) GAAALDH1A1KMT2ANPSR1NPC1
SCHEMBL27382574 0.75 ALDH1A1 (0.47) GAAALDH1A1KMT2APOLBGLA
SCHEMBL9666974 0.75 NPC1 (0.48) ALDH1A1KMT2ANPC1HTTRAB9A
SCHEMBL28766984 0.74 ALDH1A1 (0.39) ALDH1A1KMT2ANPSR1NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0337714-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1989-10-18 EP disclosed